C3 glomerulonephritis (C3GN) results from genetic or acquired dysregulation of the alternative complement pathway. A subset of patients may have clinical and biochemical characteristics compatible with an autoimmune disorder. We studied a cohort of 85 patients with confirmed C3GN (2007–2014), of which ten patients (3 male, 7 female; mean age 38.5 years) had an associated autoimmune disorder. All patients had abnormal ANA titers, 6 also had positive ds-DNA titers. At the time of presentation with C3GN, all 7 female patients had autoimmune-related presentations. Of the 3 male patients, only 1 patient had autoimmune-related presentations. Kidney biopsy showed predominantly mesangial proliferative or membranoproliferative glomerulonephritis. In 5 patients, the alternative pathway was evaluated. All had allele variants/polymorphisms associated with C3GN. One patient was also positive for C3Nefs. Treatment varied form conservative management to the use of prednisone alone or with cytotoxic therapy. Mean serum creatinine decreased from 2.0 to 1.4 mg/dL while proteinuria decreased from 2300 to 994 mg/24 h in 8 patients with follow-up. The study highlights the association between C3GN and autoimmune disorders, particularly in female patients. The study suggests that an autoimmune milieu may act as a trigger for the development of C3GN in genetically susceptible patients. Short-term prognosis of C3GN associated with autoimmune disorders appears excellent.
C3 glomerulopathy C3 glomerulonephritis Autoimmune disease ANA ds-DNA
This is a preview of subscription content, log in to check access.
Conflict of interest
This study does not contain any studies with human participants performed by any of the participants.
For this type of study formal consent is not required. The Institutional Review Board at the Mayo Clinic, Rochester, approved the study.
Servais A, Fremeaux-Bacchi V, Lequintrec M et al (2007) Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet 44:193–199CrossRefPubMedGoogle Scholar
Sethi S, Fervenza FC, Zhang Y et al (2012) C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up. Kidney Int 82:465–473CrossRefPubMedPubMedCentralGoogle Scholar
Sethi S, Fervenza FC, Zhang Y et al (2011) Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement. Clin J Am Soc Nephrol 6:1009–1017CrossRefPubMedPubMedCentralGoogle Scholar
Sethi S, Fervenza FC (2012) Membranoproliferative glomerulonephritis: a new look at an old entity. N Engl J Med 366:1119–1131CrossRefPubMedGoogle Scholar
Martínez-Barricarte R, Heurich M, Valdes-Cañedo F et al (2010) Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation. J Clin Invest 120:3702–3712CrossRefPubMedPubMedCentralGoogle Scholar
Servais A, Noel L-H, Roumenina LT et al (2012) Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int 82:454–464CrossRefPubMedGoogle Scholar
Pickering M, Cook HT (2011) Complement and glomerular disease: new insights. Curr Opin Nephrol Hypertens 20:271–277CrossRefPubMedGoogle Scholar
Ozaltin F, Li B, Rauhauser A et al (2013) DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN. J Am Soc Nephrol 24:377–384CrossRefPubMedGoogle Scholar
Sethi S, Fervenza FC, Zhang Y et al (2013) Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement. Kidney Int 83:293–299CrossRefPubMedGoogle Scholar
Maga TK, Meyer NC, Belsha C et al (2011) A novel deletion in the RCA gene cluster causes atypical hemolytic uremic syndrome. Nephrol Dial Transplant 26:739–741CrossRefPubMedGoogle Scholar
Zand L, Fervenza F, Nasr S et al (2014) Membranoproliferative glomerulonephritis associated with autoimmune diseases. J Nephrol 27:165–171CrossRefPubMedGoogle Scholar
Zipfel PF, Skerka C (2009) Complement regulators and inhibitory proteins. Nat Rev Immunol 9:729–740PubMedGoogle Scholar
Wichainun R, Kasitanon N, Wangkaew S et al (2013) Sensitivity and specificity of ANA and anti-dsDNA in the diagnosis of systemic lupus erythematosus: a comparison using control sera obtained from healthy individuals and patients with multiple medical problems. Asian Pac J Allergy Immunol 31:292–298CrossRefPubMedGoogle Scholar
Arbuckle MR, McClain MT, Rubertone MV et al (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349:1526–1533CrossRefPubMedGoogle Scholar
Nasr SH, Galgano SJ, Markowitz GS et al (2006) Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies. Kidney Int 70:2148–2151CrossRefPubMedGoogle Scholar
Larsen CP, Ambuzs JM, Bonsib SM et al (2014) Membranous-like glomerulopathy with masked IgG kappa deposits. Kidney Int 86:154–161CrossRefPubMedGoogle Scholar
Dorner T (2012) SLE in 2011: deciphering the role of NETs and networks in SLE. Nat Rev Rheumatol 8:68–70PubMedGoogle Scholar
Radic M, Marion T (2013) Neutrophil extracellular chromatin traps connect innate immune response to autoimmunity. Semin Immunopathol 35:465–480CrossRefPubMedGoogle Scholar
Sano Y, Nishimukai H, Kitamura H et al (1981) Hereditary deficiency of the third component of complement in two sisters with systemic lupus erythematosus-like symptoms. Arthritis Rheum 24:1255–1260CrossRefPubMedGoogle Scholar
Walport MJ, Davies KA, Botto M et al (1994) C3 nephritic factor and SLE: report of four cases and review of the literature. QJM 87:609–615PubMedGoogle Scholar
Carroll MC (2004) A protective role for innate immunity in systemic lupus erythematosus. Nat Rev Immunol 4:825–831CrossRefPubMedGoogle Scholar
Nozal P, Garrido S, Martínez-Ara J et al (2015) Case report: lupus nephritis with autoantibodies to complement alternative pathway proteins and C3 gene mutation. BMC Nephrol 16:40CrossRefPubMedPubMedCentralGoogle Scholar